Shares of MELA Sciences (MELA) are soaring post-session after receiving European CE Mark approval for MelaFind, its device for evaluating and detecting melanoma, allowing the company to market it to dermatologists across the EU. Shares +32% AH.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs